Variable | Group | Sub-Groups | Cutoff point | Sensitivity (%) | Specificity (%) | AUC | P-value | 95% CI Lower Bound | 95% CI Upper Bound |
---|---|---|---|---|---|---|---|---|---|
CB2 | Female | Severe Vs. Non-Severe | > 0.151 | 94 | 60 | 0.74 | 0.04 | 0.54 | 0.93 |
CB2 | Male | Severe Vs. Non-Severe | > 0.242 | 84 | 62 | 0.76 | 0.02 | 0.58 | 0.94 |
MOR | Female | Severe Vs. Non-Severe | > 0.211 | 66 | 60 | 0.72 | 0.06 | 0.51 | 0.92 |
MOR | Male | Severe Vs. Non-Severe | > 0.295 | 84 | 64 | 0.74 | 0.04 | 0.53 | 0.94 |
lL-17 | Female | Severe Vs. Non-Severe | > 35.44 | 94 | 86 | 0.97 | 0.0001 | 0.91 | 1 |
lL-17 | Male | Severe Vs. Non-Severe | > 42.91 | 87 | 67 | 0.75 | 0.01 | 0.57 | 1 |
MCP-1 | Female | Severe Vs. Non-Severe | > 67.70 | 100 | 86 | 0.93 | 0.0001 | 0.82 | 1 |
MCP-1 | Male | Severe Vs. Non-Severe | > 97.65 | 83 | 65 | 0.80 | 0.04 | 0.58 | 1 |
OPN | Female | Severe Vs. Non-Severe | > 17.84 | 94 | 86 | 0.98 | 0.0001 | 0.94 | 1 |
OPN | Male | Severe Vs. Non-Severe | > 18.26 | 85 | 60 | 0.89 | 0.0001 | 0.77 | 1 |
IFN-γ | Female | Severe Vs. Non-Severe | > 333 | 94 | 93 | 0.93 | 0.0001 | 0.93 | 1 |
IFN-γ | Male | Severe Vs. Non-Severe | > 350 | 81 | 67 | 0.76 | 0.04 | 0.54 | 0.98 |